- Home
- MOGU vs GDTC Comparison
MOGU vs GDTC Comparison
Compare MOGU & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOGU | GDTC |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | China | Singapore |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.8M | 24.8M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MOGU | GDTC |
|---|---|---|
| Price | $2.65 | $1.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.8K | ★ 135.8K |
| Earning Date | 11-21-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,462,964.00 | $573,193.00 |
| Revenue This Year | N/A | $5.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 63.03 |
| 52 Week Low | $1.83 | $1.65 |
| 52 Week High | $8.10 | $4.05 |
Technical Indicators
Market Signals| Indicator | MOGU | GDTC |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 40.07 |
| Support Level | $2.55 | $1.72 |
| Resistance Level | $2.75 | $1.88 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 58.33 | 10.33 |
Price Performance
Historical ComparisonAbout MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.